Viewing Study NCT02126150


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2025-12-27 @ 12:58 PM
Study NCT ID: NCT02126150
Status: COMPLETED
Last Update Posted: 2015-12-08
First Post: 2014-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: United Coronary Biobanks
Sponsor: UMC Utrecht
Organization:

Study Overview

Official Title: United CORoNary Biobanks
Status: COMPLETED
Status Verified Date: 2015-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: UNICORN
Brief Summary: The UNICORN consists of two collaborating biobanks, one in Utrecht and one in Singapore. From these two sites we include all patients who undergo a coronary catheterization for any reason.

At the moment of catheterization we draw blood, which will be stored in a biobank and we collect clinical characteristics. Patients are followed-up for 5 years for the occurrence of major cardiovascular events.

By including from two sites in the world we include 4 major ethnic groups: Caucasians, Chinese, Indians and Malays. We aim at including at least 2000 patients per ethnic group.

Our hypothesis is that there are differences in the risk factor burden, clinical presentation of CAD, and biochemical patterns in the blood among the ethnic groups.

Furthermore, this biobank offers a platform for multi-ethnic biomarker discovery.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: